Related Experiment Video
Updated: Sep 17, 2025

07:40
A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
Published on: August 30, 2019
9.1K
Acetic Acid Inhalation-Induced Lung Injury: A Common Chemical with Underestimated Risks
Puthiyavalappil Rasin1, Praveena Prabhakaran2
1Department of Chemistry, Sreenidhi University, Hyderabad 501301, India.
Chemical Research in Toxicology
|July 2, 2025
Summary
Inhaling acetic acid can harm your lungs. This study explores its toxic effects and recommends safety measures to prevent respiratory injury in homes and workplaces.
Area of Science:
- Toxicology
- Environmental Health
- Occupational Safety
Background:
- Acetic acid is a common chemical with widespread industrial and domestic applications.
- While its utility is recognized, the potential for respiratory harm from its inhalation is often underestimated.
- Existing safety protocols may not adequately address the specific risks associated with acetic acid vapor exposure.
Purpose of the Study:
- To investigate the toxicological mechanisms underlying respiratory damage caused by acetic acid inhalation.
- To identify and highlight the often-overlooked health risks associated with acetic acid exposure.
- To emphasize the necessity of developing and implementing targeted safety measures for lung injury prevention.
Main Methods:
- Review of existing toxicological data on acetic acid.
- Analysis of case studies related to respiratory incidents involving acetic acid.
- Literature synthesis on occupational and domestic exposure scenarios.
Main Results:
- Acetic acid inhalation can lead to acute and chronic respiratory tract irritation and injury.
- Mechanisms include direct cellular damage, inflammatory responses, and potential long-term pulmonary effects.
- Data gaps exist regarding long-term, low-level exposure risks.
Conclusions:
- The inhalation of acetic acid poses significant, yet often underestimated, respiratory health risks.
- Targeted safety interventions are crucial for mitigating lung injury in both occupational and domestic environments.
- Further research is warranted to fully elucidate long-term health consequences and refine safety guidelines.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-III
335
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
335
Acute Respiratory Failure-I
345
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
345
Acute Respiratory Failure-V
214
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
214
Acute Respiratory Failure-II
377
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
377
Inhalational Anesthetics: Overview
537
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
537
Acute Respiratory Failure-IV
238
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
238

